68Ga-DOTA-[Thi8,Met(O2)11]SP

N/A

Report date: 2025/11/20 16:04:18

NME

Base Information

Drug Name68Ga-DOTA-[Thi8,Met(O2)11]SP

Drug Alias NameN/A

ClassificationRadiation-emitting products > Nuclides > Gallium > 68GaRadiation-emitting products > Radioactive diagnostic agentRadiation-emitting products > Radionuclide Drug Conjugates +[4]

Mechanisms of ActionNeurokinin 1 receptor binders

TargetsNeurokinin 1 receptor

Therapy Area/IndicationsGlioblastoma

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritorySouth Africa

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesThe South African Nuclear Energy Corporation SOC Ltd

China Registration ClassN/A

Develop Information

Active CompaniesThe South African Nuclear Energy Corporation SOC Ltd

Inactive CompaniesN/A

Active IndicationsGlioblastoma

Inactive IndicationsN/A

Other Information

ATC CodeN/A